INS and type 2 diabetes mellitus: In a study by Ikonominis et al., T2DM patients treated with GLP-1 agonists, SGLT2-Is, and their combination, achieved after 12 months a greater improvement of endothelial glycocalyx compared to patients treated with insulin.